M D Peake

The accuracy of a pharmacokinetic theophylline predictor using once daily dosing.

H. Chrystyn, M. Peake, H Chrystyn, 1987, British journal of clinical pharmacology.

Bayesian derived predictions for twice daily theophylline under outpatient conditions and an assessment of optimal sampling times.

H. Chrystyn, M. Peake, H Chrystyn, 1989, British journal of clinical pharmacology.

Domiciliary chemotherapy with gemcitabine is safe and acceptable to advanced non-small-cell lung cancer patients: results of a feasibility study

N Thatcher, M. Peake, N. Thatcher, 2003, British Journal of Cancer.

Lung cancer: district active treatment rates affect survival

D. Forman, M. Muers, M. Peake, 2002, Journal of epidemiology and community health.